Aurora Investment Counsel Sells 682 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Aurora Investment Counsel cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.4% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,671 shares of the company’s stock after selling 682 shares during the period. Aurora Investment Counsel’s holdings in Henry Schein were worth $1,261,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Summit Securities Group LLC acquired a new position in Henry Schein in the second quarter worth $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein during the 2nd quarter worth about $37,000. Blue Trust Inc. grew its holdings in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after acquiring an additional 475 shares during the last quarter. Mather Group LLC. increased its position in Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after acquiring an additional 216 shares in the last quarter. Finally, Palisade Asset Management LLC acquired a new stake in Henry Schein in the 1st quarter valued at about $113,000. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 1.14% of the company’s stock.

Henry Schein Trading Down 0.4 %

NASDAQ:HSIC opened at $72.90 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a market capitalization of $9.33 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 2.01 and a beta of 0.86. The business’s 50-day moving average price is $70.14 and its two-hundred day moving average price is $70.17.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same period last year, the company posted $1.31 EPS. Henry Schein’s revenue for the quarter was up .0% on a year-over-year basis. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the topic of several research analyst reports. JPMorgan Chase & Co. decreased their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Robert W. Baird lowered their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Evercore ISI dropped their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. UBS Group cut their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $77.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.